Please login to the form below
29
Revenue 2017Soliris
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Soliris was produced by Alexion.
Alexion targets RNAi with $637m Dicerna deal
Alexion targets RNAi with $637m Dicerna deal. Bolsters pipeline ahead of Soliris patent protection loss. ... Alexion already has a follow-on complement inhibitor to be the next generation replacement for Soliris.
Alexion adds to pipeline with $1.2bn Syntimmune buy
Alexion adds to pipeline with $1.2bn Syntimmune buy. As company prepares for possible loss of patent protection for Soliris. ... Used to treat paroxysmal nocturnal haemoglobinuria (PNH) and myasthenia gravis, Soliris brought in sales of more than $3bn
The year of the blockbuster
These include Juno Therapeutics’CAR T-cell therapy, lisocabtagene maraleucel, for diffuse large B-cell lymphoma, and Alexion’s next-generation Soliris treatment, ravulizumab, for paroxysmal nocturnal haemoglobinuria.
Alexion uses priority review voucher for Soliris follow-up
Alexion uses priority review voucher for Soliris follow-up. Files ravulizumab for paroxysmal nocturnal haemoglobinuria. ... Alexion is pulling out all the stops to get speedy approval for a follow-up to its rare blood disorder therapy Soliris, using a
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
-
Senior Medical Writer
-
Competitive Salary
-
Medical Writers
-
Competitive Salary and Benefits
- Senior Account Executive, London, Medical Communications
-
Excellent package
-
Senior Account Manager
-
Negotiable
-
Account Director
-
Excellent benefits
- Director, Market Access / HEOR - North-West
-
Negotiable
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Senior Systematic Review Analyst - Oxford
-
Negotiable
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
Subscribe to our email news alerts
PMHub
Anthill Agency
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...
Latest intelligence
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
- World Diabetes Day: Interaction and impact of diabetes on mental health
- For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
Quick links
Infographics
